(2) Novel approach for minimizing investment risks and stretching limited budgets has 375 innovations targeting infectious diseases under development NEW YORK, Jan. 28, 2021 /PRNewswire/ -- The public-private initiatives that contributed to COVID-19 vaccine and drug development have showcased a model for accelerating biomedical innovation. However, the effectiveness of public-private partnerships in fighting global health threats had emerged long before this pandemic hit. Over the last decade, such alliances have produced a wide assortment of life-saving technologies targeting diseases that afflict billions in low-income countries, according to a new report from a group of 12 product development partnerships (PDPs) that assesses their impact and future potential.